This inventor holds 1 USPTO granted patent. Top assignees: Beijing Institute of Technology, The University of Hong Kong. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 154 
1 out of 376 
Years Active: 2007
Title: The Innovative Contributions of Marie C M Lin
Introduction
Marie C M Lin is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of cancer research through his innovative inventions. His work focuses on the mechanisms of telomerase and its implications in cancer treatment.
Latest Patents
Marie C M Lin holds a patent for "Telomerase reverse transcriptase fragments and uses thereof." This invention provides compositions comprising fragments of human telomerase reverse transcriptase (hTERT), which can lead to telomere dysfunction in a cell and a reduction of growth and tumorigenicity in cancer cells. The invention also relates to the uses of these fragments in the treatment of cancer and in drug discovery. He has 1 patent to his name.
Career Highlights
Throughout his career, Marie C M Lin has worked with esteemed institutions such as the Beijing Institute of Technology and The University of Hong Kong. His research has contributed to a deeper understanding of cancer biology and potential therapeutic approaches.
Collaborations
Marie C M Lin has collaborated with notable colleagues, including Jun Huang and Cui-Fen Huang. Their joint efforts have further advanced the research in the field of telomerase and cancer treatment.
Conclusion
Marie C M Lin's innovative work in the field of cancer research highlights the importance of telomerase in cancer biology. His contributions continue to pave the way for new therapeutic strategies and drug discovery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile